Trade

with

Ultragenyx Pharmaceutical Inc
(NASDAQ: RARE)
AdChoices
48.57
+3.18
+7.01%
After Hours :
-
-
-

Open

45.09

Previous Close

45.39

Volume (Avg)

52.64k (454.65k)

Day's Range

45.09-49.81

52Wk Range

32.02-69.77

Market Cap.

1.44B

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

31.70M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 0

    • Net Income

    • -35.07M

    • Market Cap.

    • 1.44B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 9.41

    • Price/Cash flow

    • -19.61

      • EBITDA

      • -34.63M

      • Return on Capital %

      • -29.56

      • Return on Equity %

      • -31.39

      • Return on Assets %

      • -29.56

      • Book Value/Share

      • 4.83

      • Shares Outstanding

      • 31.70M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 85.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -2.20

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 17.69

              • 2.92

              • Quick Ratio

              • 17.14

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.06

              • 2.21

              • Book Value/Share

              • 4.83

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -14.43

                • 277.78

                • P/E Ratio 5-Year High

                • -21.33

                • 634.30

                • P/E Ratio 5-Year Low

                • -9.79

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.35

                • Price/Book Value

                • 9.78

                • 8.50

                • Price/Cash Flow Ratio

                • -19.61

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -31.39

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -29.56

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -31.39

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • -

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -32.28M
                  Operating Margin
                  -
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -19.61
                  Ownership

                  Institutional Ownership

                  83.41%

                  Top 10 Institutions

                  69.88%

                  Mutual Fund Ownership

                  37.13%

                  Float

                  67.48%

                  5% / Insider Ownership

                  2.74%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Small Cap World

                  •  

                    1,628,457

                  • 4.46

                  • 5.14

                  • Columbia Acorn Fund

                  •  

                    1,624,689

                  • 0.00

                  • 5.12

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,087,727

                  • 142.11

                  • 3.43

                  • American Funds IS® Gbl Sm Cap

                  •  

                    836,206

                  • -3.46

                  • 2.64

                  • Fidelity® Select Health Care Portfolio

                  •  

                    562,900

                  • 92.31

                  • 1.78

                  • Fidelity® Growth Company Fund

                  •  

                    517,600

                  • 539.36

                  • 1.63

                  • BlackRock Health Sciences Opps Port

                  •  

                    386,105

                  • 0.00

                  • 1.22

                  • Vanguard Small Cap Index

                  •  

                    329,899

                  • 66.20

                  • 1.04

                  • Vanguard Total Stock Mkt Idx

                  •  

                    313,249

                  • 67.76

                  • 0.99

                  • SPDR® S&P Biotech ETF

                  •  

                    306,714

                  • 0.00

                  • 0.81

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • TPG Capital, L.P.

                  •  

                    3,085,240

                  • 0.00%

                  • 10.26

                  • Capital Research Global Investors

                  •  

                    2,063,176

                  • 0.00%

                  • 6.86

                  • Columbia Wanger Asset Management LLC

                  •  

                    1,793,182

                  • -0.13%

                  • 5.74

                  • Adage Capital Partners Gp LLC

                  •  

                    1,756,968

                  • -4.55%

                  • 5.84

                  • T. Rowe Price Associates, Inc.

                  •  

                    1,253,279

                  • -9.90%

                  • 3.98

                  • Wellington Management Company, LLP

                  •  

                    624,579

                  • -1.24%

                  • 2.08

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  -

                  Ultragenyx Pharmaceutical Inc is a development-stage biopharmaceutical company engaged in identifying, acquiring, developing and marketing novel products for the treatment of rare and ultra-rare disease.

                  Key People

                  Dr. Emil D. Kakkis,M.D.

                  CEO/Director/President/Founder

                  Mr. Eran Nadav

                  Chairman of the Board/Director

                  Shalini Sharp

                  CFO/Senior VP

                  Mr. Michael P. Cohrs, PhD.

                  Vice President, Divisional

                  Mr. John Ditton

                  Vice President, Divisional

                  • Ultragenyx Pharmaceutical Inc

                  • 60 Leveroni Court

                  • Novato, CA 94949

                  • USA.Map

                  • Phone: +1 415 483-8800

                  • Fax: +1 415 483-8810

                  • ultragenyx.com

                  Incorporated

                  2010

                  Employees

                  59

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: